Success Metrics

Clinical Success Rate
93.8%

Based on 121 completed trials

Completion Rate
94%(121/129)
Active Trials
10(6%)
Results Posted
29%(35 trials)
Terminated
8(5%)

Phase Distribution

Ph phase_3
31
18%
Ph phase_1
47
28%
Ph phase_4
36
21%
Ph early_phase_1
1
1%
Ph not_applicable
18
11%
Ph phase_2
33
20%

Phase Distribution

48

Early Stage

33

Mid Stage

67

Late Stage

Phase Distribution166 total trials
Early Phase 1First-in-human
1(0.6%)
Phase 1Safety & dosage
47(28.3%)
Phase 2Efficacy & side effects
33(19.9%)
Phase 3Large-scale testing
31(18.7%)
Phase 4Post-market surveillance
36(21.7%)
N/ANon-phased studies
18(10.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

93.1%

121 of 130 finished

Non-Completion Rate

6.9%

9 ended early

Currently Active

10

trials recruiting

Total Trials

168

all time

Status Distribution
Active(14)
Completed(121)
Terminated(9)
Other(24)

Detailed Status

Completed121
unknown24
Terminated8
Active, not recruiting6
Recruiting4
Not yet recruiting3

Development Timeline

Analytics

Development Status

Total Trials
168
Active
10
Success Rate
93.8%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (0.6%)
Phase 147 (28.3%)
Phase 233 (19.9%)
Phase 331 (18.7%)
Phase 436 (21.7%)
N/A18 (10.8%)

Trials by Status

recruiting42%
terminated85%
enrolling_by_invitation11%
not_yet_recruiting32%
active_not_recruiting64%
unknown2414%
withdrawn11%
completed12172%

Recent Activity

Clinical Trials (168)

Showing 20 of 168 trialsScroll for more
NCT07341100Phase 2

Study to Evaluate the Preliminary Efficacy of SKB264 and the Effect of Clarithromycin on the PK of SKB264 in OC

Active Not Recruiting
NCT05469126Phase 1

A Drug Interaction Study of Clarithromycin and LY3502970 in Healthy Participants

Completed
NCT04302324Phase 2

A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to Daratumumab

Active Not Recruiting
NCT04310930Phase 2

Finding the Optimal Regimen for Mycobacterium Abscessus Treatment

Recruiting
NCT02343042Phase 1

Selinexor and Backbone Treatments of Multiple Myeloma Patients

Active Not Recruiting
NCT04630145Phase 2

A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)

Completed
NCT07485010Phase 2

Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial

Not Yet Recruiting
NCT06837259Phase 1

A Study to Learn if Study Medicines Called Cyclosporine and Clarithromycin Affect How the Body Processes the Other Study Medicine Called PF-07328948 in Healthy Adults

Completed
NCT05926804Not Applicable

A "Screen and Treat" Helicobacter Pylori Eradication Trial in Adolescents in Three Regions of Chile

Recruiting
NCT01298336Phase 3

Treatment of Mycobacterium Xenopi Pulmonary Infection

Completed
NCT01745588Phase 2

Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma

Completed
NCT01559935Phase 2

Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Multiple Myeloma

Active Not Recruiting
NCT07040787Phase 1

Investigation of Drug-drug Interaction of HRS-5965 With Clopidogrel and Clarithromycin in Healthy Subjects

Completed
NCT07086937Not Applicable

Efficacy of Nitazoxanide Based Therapy vs Standard Triple Therapy in H-pylori in Children

Completed
NCT04026958Phase 2

Clarithromycin Mechanisms in Hypersomnia Syndromes

Completed
NCT05742568Phase 4

Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology

Completed
NCT06514274Phase 4

Study on The Efficacy and Safety of Vonoprazan-containing Berberine Triple Therapy in Helicobacter Pylori First-Line Eradication

Completed
NCT06523764Phase 4

Efficacy and Safety of Tegoprazan and Minocycline Dual Therapy for Helicobacter Pylori Initial Treatment

Active Not Recruiting
NCT07021729Phase 4

Comparison of Two Treatment Regimens of Helicobacter Pylori Infection

Not Yet Recruiting
NCT06964334Phase 3

The Effect of Vitamin D Supplement as Adjuvant Therapy in Eradication of Helicobacter Pylori Infection

Not Yet Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
168